• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Are Omega-3s Effective for ADHD?

Are Omega-3s Effective for ADHD?

December 1, 2011
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Editor-in-Chief, Caroline Fisher, PhD, MD

Omega-3 fatty acids have been extolled as a treatment for everything from depression to high blood pressure. But how do they stack up for ADHD?A recent meta-analysis set out toanswer this, compiling the results of 10 randomized placebo controlled trialsof omega-3 supplementation involving close to 700 children. Nine of the 10 trials examined omega-3 monotherapy compared to placebo; one trial compared omega-3 augmentation of traditional medication therapy to placebo.

Omega-3 supplementation showed small but significant improvement in ADHD severity, based on improvement on a number of standard rating scales (effect size 0.31). There were no significant differences in efficacy between omega-3 as a monotherapy and omega-3 augmentation.

Omega-3 supplements come in a variety of doses, with many different bal- ances of eicosapentaenoic acid (EPA) and docosahexanoic acid (DHA). Researchers found that EPA dose within the supple- ment had a strong correlation with improved ADHD symptoms. The greatest effect size was seen with doses of EPA between 450 and 600 mg (Bloch MH and Qawasmi A, JAACAP 2011;50(10):991– 1000).

CCPR’s Take: Omega-3s certainly don’t have the same effect size as our usual treatments for ADHD— methylphenidate, 0.78; clonidine, 0.58; and atomoxetine, 0.64 (Schachter HM et al, CMAJ 2001;165:1475–1488; Connor DF et al, JAACAP 1999;38:1551–1559; Cheng JY et al, Psychopharmacology (Berl) 2007;194:197–209). In addition, it’s well established that omega-3s can be helpful in treating depression, so we are left to wonder if some of the effect here was seen in kids whose ADHD was exacerbated by depression. Regardless, for some kids who either have trouble with traditional meds or whose parents are opposed to them, you might want to suggest omega-3 fatty acids. They have hardly any side effects, and they may help. Just be sure to recommend that patients or their parents look for higher doses of EPA for the best results.

Child Psychiatry
KEYWORDS adhd child-psychiatry natural_medications research_updates
    www.thecarlatreport.com
    Issue Date: December 1, 2011
    SUBSCRIBE NOW
    Table Of Contents
    Are Omega-3s Effective for ADHD?
    The Psychopharmacology of Anxiety Treatment in Children and Adolescents
    Effective Psychotherapies for Childhood Anxiety
    Treating Anxiety in Children and Adolescents
    DOWNLOAD NOW
    Featured Book
    • PB4e_Cover2.png

      Psychiatry Practice Boosters, Fourth Edition (2023)

      Teaches you the key points of 63 of the most clinically relevant studies in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.